Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PhiTech logo — Multi-omics AI for Precision Medicine

PhiTech

Multi-omics AI for Precision Medicine

Founded 2013 Turkey Turkey 27 employees Unknown Total: $7.25M Biopharma, Biotechnology

General Information

Company Name PhiTech
Founded Year 2013
Location Turkey Turkey +3
Employees 27
Industries Biopharma, Biotechnology
Funding Stage Unknown
Social

Get notified when PhiTech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Award Received Sep 11, 2026

PhiTech was recently featured on Forbes Türkiye’s “Girişim 2026” list as a standout startup.

Market Expansion Sep 09, 2026

PhiTech announced its official market entry into the Netherlands, specifically establishing a presence in Amsterdam.

Get alerts when PhiTech shows new signals

About PhiTech

PhiTech, founded in 2013 and headquartered in Turkey, is at the forefront of biopharma innovation. Specializing in multi-omics AI, the company integrates DNA and RNA sequencing with artificial intelligence to advance diagnostics for rare diseases. This positions PhiTech uniquely within the Biopharma and Biotechnology industries.

The company's commitment to precision medicine is encapsulated in its slogan, "Multi-omics AI for Precision Medicine." With a focus on applying cutting-edge technology to genetic data, PhiTech is pioneering new pathways in the medical field.

The company's most recent financial milestone was securing a $2.40M Early VC investment on 01 April 2026. This injection of capital was led by a diverse group of investors including Arka Venture Labs, Eksim Ventures, Founder One, Enter Capital, İTK Ventures, IST Capital, TechnoBee, and Osman Alp Arlı. This backing underscores investor confidence in PhiTech's innovative approach and potential for significant industry impact.

Taxonomy: Multi-omics, Precision Medicine, DNA Sequencing, RNA Sequencing, AI Diagnostics, Rare Disease Diagnostics, Bioinformatics, Genomics, Transcriptomics, Epigenomics, Healthcare Innovation, Disease Sequencing

Services & Products

Integrating genomics and transcriptomics for diagnosis
Automated gene prioritization
RNA-Seq data analysis
AI-driven interpretation of genetic data
Comprehensive diagnostic profiling

Target Customers

Diagnostic Laboratories Hospitals & Clinics Academic & Research Centers Biopharma Companies Contract Research Organizations (CROs)

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• 8
Investor Investor Investor Investor Investor
•••• •••• 		01 Apr 2026
Early VC •••••• 1
Investor
01 Sep 2025
Seed •••••• 1
Investor
01 Mar 2024
Seed •••••• 1
Investor
01 Nov 2023
Seed •••••• 11
Investor
•••• •••• 		01 Mar 2023

Latest News

View All
Genom ve yapay zeka teknolojilerini nadir hastalıklar için birleştiren PhiTech, 1.1 milyon dolar yat... — Webrazzi.com
Genom ve yapay zeka teknolojilerini nadir hastalıklar için birleştiren PhiTech, 1.1 milyon dolar yatırım aldı
Webrazzi.com Mar 08, 2024
Eksim Ventures dijital sağlıkta iki yatırıma imza attı — Aa.com.tr
Eksim Ventures dijital sağlıkta iki yatırıma imza attı
Aa.com.tr Sep 18, 2025
Eksim Ventures, SmartAlpha ve PhiTech'e yatırım yaptı — Webrazzi
Eksim Ventures, SmartAlpha ve PhiTech'e yatırım yaptı
Webrazzi Sep 18, 2025

PhiTech Alternatives & Competitors

View All Alternatives
PhiTech vs
Personalbio
Personalbio

Empowering health management and enhancing quality of life with advanced gene sequencing and biotech...

Series A
28 employees
Biotechnology, Health Care
Compare PhiTech vs Personalbio
PhiTech vs
Personal Genomics
Personal Genomics Italy

Personal Genomics mette la genomica a disposizione della clinica con le più recenti tecnologie di se...

30 employees
Health Care, Health and Wellness
Compare PhiTech vs Personal Genomics
PhiTech vs
Veritas Intercontinental
Veritas Intercontinental Spain

🧬Sequencing your genome is the first step in a life-changing journey | Get more info: www.veritasin...

Series A
68 employees
Biotechnology, Life Sciences
Compare PhiTech vs Veritas Intercontinental
View all alternatives

FAQ About PhiTech

Multi-omics AI for Precision Medicine
PhiTech was founded in 2013.
PhiTech is headquartered in Turkey.
PhiTech operates in the following industries: Biopharma, Biotechnology.
PhiTech has approximately 27 employees.
PhiTech has completed 5 funding rounds, raising a total of $7.25M. The latest funding stage is Unknown.
PhiTech offers: Integrating genomics and transcriptomics for diagnosis, Automated gene prioritization, RNA-Seq data analysis, AI-driven interpretation of genetic data, Comprehensive diagnostic profiling.
Top alternatives and competitors to PhiTech include Personalbio, Personal Genomics, Veritas Intercontinental, einocle, GeneMind Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PhiTech and Personalbio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PhiTech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy